PARSIPPANY, N.J. — PARSIPPANY, N.J. — IVERIC bio, Inc. on Wednesday reported a loss of $72.2 million in its first quarter. The Parsippany, New Jersey-based company said it had a. | May 11, 2023
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of IVERIC bio, Inc. to Astellas Pharma Inc. Under. | May 2, 2023
By Kosaku Narioka Astellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its capabilities in the ophthalmology field. The Japanese. | May 1, 2023
Astellas Pharma Inc. said Monday it will buy U.S. pharmaceutical company Iveric Bio Inc. for about $5.9 billion in its largest takeover, as the Japanese drugmaker pushes ahead with its acquisition. | May 1, 2023